Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors; D014031:Tobramycin / Q000008:administration & dosage* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014031:Tobramycin